- Filed
- Mar 31, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 27, 2026 | 5.15M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 3.87M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 3.86M sh |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$8.74M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$13.86M |
| Long Term Debt | FY 2025 · Dec 31, 2025 | $3.49M |
| Long Term Debt | FY 2025 · Dec 31, 2024 | $2M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $501.3K |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $230.36K |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | −$1.89M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $15.84M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $165.02M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $8.75M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $16.2M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $12.23M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $18.22M |
| Current Assets | FY 2025 · Dec 31, 2025 | $10.32M |
| Current Assets | FY 2025 · Dec 31, 2024 | $11.34M |
| Total Assets | FY 2025 · Dec 31, 2025 | $10.34M |
| Total Assets | FY 2025 · Dec 31, 2024 | $34.06M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$4.77 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$38.65 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$4.77 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$38.65 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $4.01M |
| Sga Expense restated | FY 2025 · Dec 31, 2024 | $9.04M |
| Net Income | FY 2025 · Dec 31, 2025 | −$18.49M |
| Net Income | FY 2025 · Dec 31, 2024 | −$149.19M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$4.02M |
| Operating Income restated | FY 2025 · Dec 31, 2024 | −$9.63M |
| Capex | FY 2025 · Dec 31, 2024 | $2.93M |
| Short Term Debt | FY 2025 · Dec 31, 2024 | $1.26M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $203.3K |